<div class="tabs-content">
  <section class="content relative active">
    <figure class="panel callout" data-bg>
      <div>
        <h1><small>For the treatment of partial-onset seizures <br class="portrait">as monotherapy or adjunctive therapy</small>ANTISEIZURE THERAPY FINE-TUNED <br class="landscape">FOR <br class="portrait">YOUR PATIENTS</h1>
      </div>
    </figure>
    <h3>APTIOM is a once-daily AED in the dibenzazepine <br class="portrait">carboxamide class&sup1;</h3>
    <ul class="disc">
      <li>Proven seizure reduction as adjunctive therapy in 3 double-blind, <br class="portrait">placebo-controlled studies&sup1;</li>
      <li>Proven effective as monotherapy in 2 dose-blinded, historical-control studies&sup1;</li>
      <li>The most frequently reported adverse reactions in patients receiving APTIOM as adjunctive therapy at doses of 800&nbsp;mg or 1200&nbsp;mg (&ge;4% and &ge;2% greater than placebo) were dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, and&nbsp;tremor&sup1;</li>
      <li>In adjunctive clinical studies, incidence of most common adverse reactions was generally lower when initiating APTIOM at 400&nbsp;mg without concomitant carbamazepine&sup2;</li>
      <li>Once-daily immediate-release AED therapyâ€”can be taken either whole or crushed, with or <br class="portrait">without food&sup1;</li>
    </ul>
  	<aside data-isi-link></aside>
    <p class="portrait">Please see Important Safety Information and Full Prescribing Information</p>
  </section>
</div>